Abstract
Spinal cord injury (SCI) is accompanied by intractable pain as well as loss of motor and visceral control. As part of an overall strategy in patient rehabilitation and improvement in quality of life, pain management is crucial. Interestingly, SCI patients report pain below the level of injury that has characteristics of neuropathic-type pain. Preclinical studies suggest that a key substrate that underlies the symptoms of neuropathic pain such as spontaneous pain and belowlevel cutaneous hypersensitivity is aberrant activity of spinal dorsal horn neurons. While pharmacotherapies for peripheral neuropathic pain exist, these treatments may lead to adverse side effects in SCI patients, such as muscle weakness and constipation, which may exacerbate existing dysfunctions. Thus, novel therapeutic strategies are needed. One way to limit the adverse effects associated with systemically administered drugs is intrathecal delivery. Intrathecal delivery also directs drug to dorsal horn neurons. Another way to reduce the severity of side effects and to potentially enhance drug efficacy is to utilize combination drug therapy. While the conopeptide ziconotide has demonstrated clinical efficacy for severe chronic pain, a limitation of this drug is its potential for significant side effects. Combinations of conopeptides with currently available drugs as well as with other conopeptides could be an effective means of reducing neuropathic SCI pain.
Keywords: Allodynia, combination drug therapy, hyperalgesia, intrathecal drug delivery, conotoxin, synergism.
Current Protein & Peptide Science
Title:Use of Naturally Occurring Peptides for Neuropathic Spinal Cord Injury Pain
Volume: 14 Issue: 3
Author(s): Aldric Hama and Jacqueline Sagen
Affiliation:
Keywords: Allodynia, combination drug therapy, hyperalgesia, intrathecal drug delivery, conotoxin, synergism.
Abstract: Spinal cord injury (SCI) is accompanied by intractable pain as well as loss of motor and visceral control. As part of an overall strategy in patient rehabilitation and improvement in quality of life, pain management is crucial. Interestingly, SCI patients report pain below the level of injury that has characteristics of neuropathic-type pain. Preclinical studies suggest that a key substrate that underlies the symptoms of neuropathic pain such as spontaneous pain and belowlevel cutaneous hypersensitivity is aberrant activity of spinal dorsal horn neurons. While pharmacotherapies for peripheral neuropathic pain exist, these treatments may lead to adverse side effects in SCI patients, such as muscle weakness and constipation, which may exacerbate existing dysfunctions. Thus, novel therapeutic strategies are needed. One way to limit the adverse effects associated with systemically administered drugs is intrathecal delivery. Intrathecal delivery also directs drug to dorsal horn neurons. Another way to reduce the severity of side effects and to potentially enhance drug efficacy is to utilize combination drug therapy. While the conopeptide ziconotide has demonstrated clinical efficacy for severe chronic pain, a limitation of this drug is its potential for significant side effects. Combinations of conopeptides with currently available drugs as well as with other conopeptides could be an effective means of reducing neuropathic SCI pain.
Export Options
About this article
Cite this article as:
Hama Aldric and Sagen Jacqueline, Use of Naturally Occurring Peptides for Neuropathic Spinal Cord Injury Pain, Current Protein & Peptide Science 2013; 14 (3) . https://dx.doi.org/10.2174/13892037113149990035
DOI https://dx.doi.org/10.2174/13892037113149990035 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
Call for Papers in Thematic Issues
Advancements in Proteomic and Peptidomic Approaches in Cancer Immunotherapy: Unveiling the Immune Microenvironment
The scope of this thematic issue centers on the integration of proteomic and peptidomic technologies into the field of cancer immunotherapy, with a particular emphasis on exploring the tumor immune microenvironment. This issue aims to gather contributions that illustrate the application of these advanced methodologies in unveiling the complex interplay ...read more
Artificial Intelligence for Protein Research
Protein research, essential for understanding biological processes and creating therapeutics, faces challenges due to the intricate nature of protein structures and functions. Traditional methods are limited in exploring the vast protein sequence space efficiently. Artificial intelligence (AI) and machine learning (ML) offer promising solutions by improving predictions and speeding up ...read more
Nutrition and Metabolism in Musculoskeletal Diseases
The musculoskeletal system consists mainly of cartilage, bone, muscles, tendons, connective tissue and ligaments. Balanced metabolism is of vital importance for the homeostasis of the musculoskeletal system. A series of musculoskeletal diseases (for example, sarcopenia, osteoporosis) are resulted from the dysregulated metabolism of the musculoskeletal system. Furthermore, metabolic diseases (such ...read more
Protein Folding, Aggregation and Liquid-Liquid Phase Separation
Protein folding, misfolding and aggregation remain one of the main problems of interdisciplinary science not only because many questions are still open, but also because they are important from the point of view of practical application. Protein aggregation and formation of fibrillar structures, for example, is a hallmark of a ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Opening New Scenarios for Human MAO Inhibitors
Central Nervous System Agents in Medicinal Chemistry Agonists of the Tissue-Protective Erythropoietin Receptor in the Treatment of Parkinson’s Disease
Current Topics in Medicinal Chemistry Multilevel Analysis of Locomotion in Immature Preparations Suggests Innovative Strategies to Reactivate Stepping after Spinal Cord Injury
Current Pharmaceutical Design Contribution of Inflammatory Processes to Nerve Cell Toxicity by Bilirubin and Efficacy of Potential Therapeutic Agents
Current Pharmaceutical Design Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Apoptosis
Current Pharmaceutical Design Subject Index to Volume 5
Current Pharmaceutical Biotechnology Visual Sexual Stimulation and Erection, a Brief Review with New fMRI Data
Current Medicinal Chemistry Erythropoietin and mTOR: A “One-Two Punch” for Aging-Related Disorders Accompanied by Enhanced Life Expectancy
Current Neurovascular Research Structural Approaches to Explain the Selectivity of COX-2 Inhibitors: Is There a Common Pharmacophore?
Current Medicinal Chemistry Recent Progress and Related Patents on the Applications of Bone Marrow-Derived Stem/Progenitor Cells in Regenerative Medicine and Cancer Therapies
Recent Patents on Regenerative Medicine Sub-Chronic Exposure of Non-Observable Adverse Effect Dose of Terbufos Sulfone: Neuroinflammation in Diabetic and Non-Diabetic Rats
CNS & Neurological Disorders - Drug Targets Thermally Activated Noble Metal Nanoparticles Incorporated in Electrospun Fiber-based Drug Delivery Systems
Current Nanomaterials Childhood Infectious Encephalitis: An Overview of Clinical Features, Investigations, Treatment, and Recent Patents
Recent Patents on Inflammation & Allergy Drug Discovery Cardiovascular Consequences of Weightlessness Promote Advances in Clinical and Trauma Care
Current Pharmaceutical Biotechnology Antipsychotics as Psychosis Drugs and Neuroprotective Promoters Evaluated by Chemical QSAR - in silico and in vivo Studies
Letters in Drug Design & Discovery Local Drug Delivery to Inner Ear for Treatment of Hearing Loss
Current Drug Therapy Coenzyme Q10 in Neuromuscular and Neurodegenerative Disorders
Current Drug Targets Molecular Biomarkers for Amyotrophic Lateral Sclerosis
Current Bioinformatics Mesenchymal Stem Cells: Potential in Treatment of Neurodegenerative Diseases
Current Stem Cell Research & Therapy Perspectives On Membrane-associated Progesterone Receptors As Prospective Therapeutic Targets
Current Drug Targets